| Net Cash Provided by (Used in) Operating Activities |
$179,534 |
USD |
-98% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,014,065 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,021,944 |
USD |
74% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
422,584,729 |
shares |
8.2% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,215,543 |
USD |
-71% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$299,936 |
USD |
23% |
Q4 2024 |
FY 2024 |
| Depreciation |
$180,904 |
USD |
-40% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,104,799 |
USD |
68% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$451,900 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$94,440 |
USD |
-40% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
15,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$14,594,216 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$449,716 |
USD |
-68% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q3 2025 |